<p>Minimal Clinically Important Difference in Barthel Index Dyspnea in Patients with COPD</p>
نویسندگان
چکیده
منابع مشابه
The Barthel index-dyspnea: a new two-dimensional dyspnea scale
and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, pleas...
متن کاملDevelopment of a Barthel Index based on dyspnea for patients with respiratory diseases
BACKGROUND As Barthel Index (BI) quantifies motor impairment but not breathlessness, the use of only this index could underestimate disability in chronic respiratory disease (CRD). To our knowledge, no study evaluates both motor and respiratory disability in CRD during activities of daily living (ADLs) simultaneously and with a unique tool. The objective of this study was to propose for patient...
متن کاملThe Significance of BODE (BMI, Obstruction, Dyspnea, Exercise) Index in Patients with Mustard Lung
Introduction: Chronic Obstructive Pulmonary Disease (COPD) secondary to sulfur mustard exposure, known as mustard lung, is an important late pulmonary complication. The BODE (Body mass index, Obstruction, Dyspnea, and Exercise) index has been established as a valuable tool for determining the adverse consequences of COPD. The aim of this study was to evaluate the role of the BODE index in pat...
متن کاملBarthel Index and Clinical Outcome in Elderly
Objectives: Among the elderly patients who are admitted in emergency departments, there is a sub-population of frail elderly who needs particular attention. The purpose of this study was to explore relationship between Barthel index and clinical outcome in elderly patients aged over 60 during a week follow up after initial admission. Methods & Materials: The method was a prospective cohort s...
متن کاملMinimal clinically important difference: defining what really matters to patients.
When assessing the clinical utility of therapies intended to improve subjective outcomes, the amount of improvement that is important to patients must be determined.1 The smallest benefit of value to patients is called the minimal clinically important difference (MCID). The MCID is a patient-centered concept, capturing both the magnitude of the improvement and also the value patients place on t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Chronic Obstructive Pulmonary Disease
سال: 2020
ISSN: 1178-2005
DOI: 10.2147/copd.s266243